+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Softgel Capsules Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6083506
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Softgel Capsules Market grew from USD 4.48 billion in 2024 to USD 4.84 billion in 2025. It is expected to continue growing at a CAGR of 7.78%, reaching USD 7.02 billion by 2030.

The softgel capsules market has evolved into a cornerstone of modern nutraceutical and pharmaceutical delivery, driven by advances in formulation science and consumer demand for convenient, bioavailable dosage forms. As manufacturers refine encapsulation techniques and integrate novel excipients, stakeholders must navigate complex regulatory frameworks, raw material supply constraints, and evolving consumer preferences. This executive summary distills critical market developments, highlighting how shifts in ingredient sourcing, sustainability imperatives, and trade policies are reshaping competitive dynamics. By understanding these forces, industry decision-makers can pinpoint strategic opportunities, optimize product portfolios, and reinforce operational resilience. This introduction sets the stage for an in-depth exploration of transformative shifts, tariff impacts, segmentation drivers, regional trends, leading company strategies, actionable recommendations, and a compelling call to action.

Transformative Shifts in the Softgel Capsule Landscape

The softgel capsule landscape is undergoing transformative change as sustainability, personalization, and advanced delivery drive innovation. Manufacturers are transitioning from traditional gelatin bases to plant-derived and marine-origin alternatives, catering to vegan and halal requirements while minimizing environmental impact. Concurrently, precision encapsulation technologies are enabling targeted release profiles, improving bioavailability for sensitive nutraceutical actives such as omega-3 and probiotic strains. Regulatory bodies worldwide are tightening quality and traceability standards, prompting investment in blockchain-enabled supply chain monitoring and enhanced GMP compliance. Meanwhile, consumer demand for clean-label, functional formats has spurred the development of modified pullulan and tapioca-starch capsules. Together, these shifts are redefining product development pipelines, forging new partnerships between ingredient innovators, contract manufacturers, and brand owners.

Cumulative Impact of United States Tariffs in 2025 on Softgel Capsules

In 2025, U.S. tariffs targeting key inputs-particularly gelatin components sourced from bovine and porcine origins in major exporting nations-have exerted cumulative pressure on production costs across the softgel supply chain. Manufacturers reliant on imported pullulan and marine extracts face increased landed costs, which are cascading into higher contract manufacturing fees and margin compression for finished dosages. In response, firms are accelerating onshore compounding of excipients and diversifying supplier bases to include domestic tapioca-starch and modified pullulan producers. These measures mitigate exposure to tariff volatility and safeguard ingredient quality. Additionally, regulatory scrutiny of imported raw materials has intensified, prompting stricter documentation requirements and prolonging lead times. Such challenges underscore the need for agile sourcing strategies and strategic inventory management to maintain uninterrupted production.

Key Segmentation Insights Shaping Product Development and Market Positioning

Insightful segmentation reveals nuanced drivers for tailored product offerings. Within product type, gelatin capsules continue to dominate but face competition from non-gelatin alternatives such as pullulan derived from tapioca-starch, with innovation extending to modified pullulan to enhance stability. Application segmentation shows nutraceutical formats like vitamins and minerals-especially omega-3 variants sourced from algal oil and fish oil-gaining traction alongside pharmaceutical prescriptions, including antibiotics and supplemental therapies. End-user analysis highlights varied consumption patterns among adults, geriatric groups split between active elderly and assisted-living cohorts, and pediatric formulations designed for palatability. The nature of raw material distinguishes animal-based sources, including bovine and marine origins, from plant-derived excipients. Dosage form preferences range from convenient monodose units to polydose systems featuring daily and weekly packs. Source segmentation underscores a shift toward natural ingredients, with marine-origin and plant-based materials-fish-derived and seaweed-derived-capturing premium positioning. Finally, end-industry perspectives illustrate strong demand from the food and beverage sector, where energy supplements and functional foods leverage softgel delivery, coexisting with sustained growth in pharmaceutical pipelines.

Key Regional Insights Driving Market Opportunities

Regional dynamics reveal diverse opportunity landscapes for softgel manufacturers. In the Americas, robust consumer awareness and a mature nutraceutical market support premium formulations, while rising healthcare expenditures in Latin America drive pharmaceutical softgel adoption. Europe, the Middle East & Africa exhibit stringent regulatory frameworks and a growing appetite for vegan-friendly capsules, prompting manufacturers to secure halal and plant-based certifications. In the Asia-Pacific region, burgeoning middle-class populations and expanding contract manufacturing infrastructure position it as a global production hub; domestic brands are increasingly integrating advanced excipients to meet escalating quality standards. Across all regions, localized preferences-whether in dosages, ingredient sourcing, or compliance requirements-demand tailored go-to-market strategies that align with regional regulatory and consumer landscapes.

Key Company Strategies Highlighting Competitive Strengths

Leading players demonstrate strategic differentiation through integrated capabilities and focused expertise. Aenova Group GmbH leverages extensive European contract manufacturing networks, while Amway Corporation capitalizes on direct-to-consumer reach in nutraceuticals. BASF SE drives excipient innovation, and Captek Softgel International Inc excels in specialized international softgel formulations. Catalent, Inc. offers comprehensive end-to-end solutions from development to commercial supply. Curtis Health Caps focuses on high-purity nutraceutical capsules, whereas Delpharm integrates formulation services across pharmaceutical and wellness sectors. Elnova Pharma targets prescription markets, and Fortunelabs emphasizes rapid R&D cycles. Fuji Capsules Co Ltd. delivers precision encapsulation, complemented by Hunan Kang Pharmaceutical Limited’s robust domestic capacity. InovoBiologic Inc. pioneers biotech-driven ingredients, backstopped by International Flavors & Fragrances Inc.’s sensory science. Marksans Pharma Limited addresses generic softgel prescriptions, while Natural Factors and Nature’s Bounty Co. reinforce consumer trust with natural formulations. Qualicaps Co., Ltd. advances capsule technology, and Rocket Science Supplements Ltd. specializes in performance supplements. Roquette Frères champions plant-based polysaccharide excipients, and SaintyCo provides custom development services. Sirio Pharma Co., Ltd. by Pfizer Inc. integrates global pharmaceutical expertise, mirroring Soft Gel Technologies, Inc.’s scalable operations and Softigel by Procaps Group’s Latin American presence. Strides Pharma Science Limited extends contract development, while Thermo Fisher Scientific, Inc. underpins analytical and manufacturing support. Trigen Laboratories Inc. excels in niche formulations, United Laboratories in high-volume output, Weihai Baihe Biology Technological Co Ltd. in marine collagen, and Yuwang Group in starch-derived capsules. Together, these companies shape competitive dynamics through differentiated service offerings, geographic reach, and technology leadership.

Actionable Recommendations for Industry Leaders to Maximize Growth

Industry leaders should prioritize supply chain resilience by diversifying raw material sources, including increased partnerships with domestic pullulan and tapioca-starch producers to offset tariff exposure. Investing in sustainable, plant-based, and marine-origin excipients will capture the growing demand for clean-label formulations. Incorporating advanced encapsulation technologies-such as targeted release and biopolymer innovations-can enhance product efficacy while distinguishing brand portfolios. Companies should also tailor offerings to high-value segments, including omega-3 algal oil capsules and personalized geriatric nutrition. Expanding manufacturing footprints in Asia-Pacific and the Americas through joint ventures will optimize cost structures and shorten lead times. Strategic collaborations with regulatory bodies and certification agencies will expedite market entry, while digital marketing and e-commerce investments will deepen consumer engagement. Finally, adopting lean, flexible production systems will help mitigate cost fluctuations and maintain competitive margins.

Conclusion: Positioning for Sustainable Leadership in the Softgel Capsule Sector

As the softgel capsule sector continues to evolve, companies that embrace innovation, sustainability, and operational agility will secure lasting competitive advantage. Transformative shifts in raw material sourcing, driven by consumer demand for clean labeling and ethical formulations, underscore the need for adaptive supply chains. Tariff-induced cost pressures highlight the importance of near-shore manufacturing and diversified procurement strategies. Segmentation analysis reveals targeted opportunities across product types, applications, and demographics, while regional insights call for tailoring to local regulatory and market dynamics. Leading firms demonstrate that integrated development capabilities, end-to-end services, and technology leadership form the backbone of market success. By aligning strategic investments with emerging trends and maintaining rigorous quality standards, industry participants can navigate complexity and drive sustainable growth.

Market Segmentation & Coverage

This research report categorizes the Softgel Capsules Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Gelatin Capsules
    • Bovine Gelatin
    • Porcine Gelatin
  • Non-Gelatin Capsules
    • Pullulan
      • Modified Pullulan
    • Tapioca-Starch
  • Nutraceutical
    • Vitamins And Minerals
      • Omega-3
        • Algal Oil
        • Fish Oil
      • Vitamin B Complex
  • Pharmaceutical
    • Prescription
      • Antibiotics
      • Supplements
  • Adults
  • Geriatric
    • Active Elderly
    • Assisted Living
  • Pediatric
  • Animal-Based
    • Bovine Source
    • Marine Source
  • Monodose
  • Polydose
    • Daily Pack
    • Weekly Pack
  • Natural
    • Marine-Origin
      • Fish Derived
      • Seaweed Derived
    • Plant-Based
  • Synthetic
  • Food And Beverage Industry
    • Energy Supplements
    • Functional Foods
  • Pharmaceutical Industry

This research report categorizes the Softgel Capsules Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Softgel Capsules Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Aenova Group GmbH
  • Amway Corporation
  • BASF SE
  • Captek Softgel International Inc
  • Catalent, Inc.
  • Curtis Health Caps
  • Delpharm
  • Elnova Pharma
  • Fortunelabs
  • Fuji Capsules Co Ltd.
  • Hunan Kang Pharmaceutical Limited
  • InovoBiologic Inc.
  • International Flavors & Fragrances Inc.
  • Marksans Pharma Limited
  • Natural Factors
  • Nature's Bounty Co.
  • Qualicaps Co., Ltd.
  • Rocket Science Supplements Ltd.
  • Roquette Frères
  • SaintyCo
  • Sirio Pharma Co., Ltd. by Pfizer Inc.
  • Soft Gel Technologies, Inc.
  • Softigel by Procaps Group
  • Strides Pharma Science Limited
  • Thermo Fisher Scientific, Inc.
  • Trigen Laboratories Inc.
  • United Laboratories
  • Weihai Baihe Biology Technological Co Ltd.
  • Yuwang Group

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Softgel Capsules Market, by Product Type
8.1. Introduction
8.2. Gelatin Capsules
8.2.1. Bovine Gelatin
8.2.2. Porcine Gelatin
8.3. Non-Gelatin Capsules
8.3.1. Pullulan
8.3.1.1. Modified Pullulan
8.3.2. Tapioca-Starch
9. Softgel Capsules Market, by Application
9.1. Introduction
9.2. Nutraceutical
9.2.1. Vitamins And Minerals
9.2.1.1. Omega-3
9.2.1.1.1. Algal Oil
9.2.1.1.2. Fish Oil
9.2.1.2. Vitamin B Complex
9.3. Pharmaceutical
9.3.1. Prescription
9.3.1.1. Antibiotics
9.3.1.2. Supplements
10. Softgel Capsules Market, by End-User
10.1. Introduction
10.2. Adults
10.3. Geriatric
10.3.1. Active Elderly
10.3.2. Assisted Living
10.4. Pediatric
11. Softgel Capsules Market, by Nature Of Raw Material
11.1. Introduction
11.2. Animal-Based
11.2.1. Bovine Source
11.2.2. Marine Source
12. Softgel Capsules Market, by Dosage Form
12.1. Introduction
12.2. Monodose
12.3. Polydose
12.3.1. Daily Pack
12.3.2. Weekly Pack
13. Softgel Capsules Market, by Source
13.1. Introduction
13.2. Natural
13.2.1. Marine-Origin
13.2.1.1. Fish Derived
13.2.1.2. Seaweed Derived
13.2.2. Plant-Based
13.3. Synthetic
14. Softgel Capsules Market, by End Industry
14.1. Introduction
14.2. Food And Beverage Industry
14.2.1. Energy Supplements
14.2.2. Functional Foods
14.3. Pharmaceutical Industry
15. Americas Softgel Capsules Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Softgel Capsules Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Softgel Capsules Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Aenova Group GmbH
18.3.2. Amway Corporation
18.3.3. BASF SE
18.3.4. Captek Softgel International Inc
18.3.5. Catalent, Inc.
18.3.6. Curtis Health Caps
18.3.7. Delpharm
18.3.8. Elnova Pharma
18.3.9. Fortunelabs
18.3.10. Fuji Capsules Co Ltd.
18.3.11. Hunan Kang Pharmaceutical Limited
18.3.12. InovoBiologic Inc.
18.3.13. International Flavors & Fragrances Inc.
18.3.14. Marksans Pharma Limited
18.3.15. Natural Factors
18.3.16. Nature's Bounty Co.
18.3.17. Qualicaps Co., Ltd.
18.3.18. Rocket Science Supplements Ltd.
18.3.19. Roquette Frères
18.3.20. SaintyCo
18.3.21. Sirio Pharma Co., Ltd. by Pfizer Inc.
18.3.22. Soft Gel Technologies, Inc.
18.3.23. Softigel by Procaps Group
18.3.24. Strides Pharma Science Limited
18.3.25. Thermo Fisher Scientific, Inc.
18.3.26. Trigen Laboratories Inc.
18.3.27. United Laboratories
18.3.28. Weihai Baihe Biology Technological Co Ltd.
18.3.29. Yuwang Group
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. SOFTGEL CAPSULES MARKET MULTI-CURRENCY
FIGURE 2. SOFTGEL CAPSULES MARKET MULTI-LANGUAGE
FIGURE 3. SOFTGEL CAPSULES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SOFTGEL CAPSULES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY NATURE OF RAW MATERIAL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY NATURE OF RAW MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY END INDUSTRY, 2024 VS 2030 (%)
FIGURE 20. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY END INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. SOFTGEL CAPSULES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. SOFTGEL CAPSULES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SOFTGEL CAPSULES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SOFTGEL CAPSULES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY GELATIN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY BOVINE GELATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY PORCINE GELATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY NON-GELATIN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY PULLULAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY MODIFIED PULLULAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY PULLULAN, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY TAPIOCA-STARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY NON-GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY NUTRACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY VITAMINS AND MINERALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY OMEGA-3, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY ALGAL OIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY FISH OIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY OMEGA-3, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY VITAMIN B COMPLEX, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY VITAMINS AND MINERALS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY ACTIVE ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY ASSISTED LIVING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY NATURE OF RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY ANIMAL-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY BOVINE SOURCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY MARINE SOURCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY MONODOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY POLYDOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY DAILY PACK, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY WEEKLY PACK, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY POLYDOSE, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY MARINE-ORIGIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY FISH DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY SEAWEED DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY MARINE-ORIGIN, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY PLANT-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY END INDUSTRY, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY ENERGY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY NON-GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY PULLULAN, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY VITAMINS AND MINERALS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY OMEGA-3, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY NATURE OF RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY POLYDOSE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY MARINE-ORIGIN, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY END INDUSTRY, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY NON-GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY PULLULAN, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY VITAMINS AND MINERALS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY OMEGA-3, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY NATURE OF RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY POLYDOSE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY MARINE-ORIGIN, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY END INDUSTRY, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY NON-GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY PULLULAN, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY VITAMINS AND MINERALS, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY OMEGA-3, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY NATURE OF RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY POLYDOSE, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY MARINE-ORIGIN, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY END INDUSTRY, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, 2018-2030 (USD MILLION)
TABLE 130. CANADA SOFTGEL CAPSULES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. CANADA SOFTGEL CAPSULES MARKET SIZE, BY GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 132. CANADA SOFTGEL CAPSULES MARKET SIZE, BY NON-GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 133. CANADA SOFTGEL CAPSULES MARKET SIZE, BY PULLULAN, 2018-2030 (USD MILLION)
TABLE 134. CANADA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. CANADA SOFTGEL CAPSULES MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 136. CANADA SOFTGEL CAPSULES MARKET SIZE, BY VITAMINS AND MINERALS, 2018-2030 (USD MILLION)
TABLE 137. CANADA SOFTGEL CAPSULES MARKET SIZE, BY OMEGA-3, 2018-2030 (USD MILLION)
TABLE 138. CANADA SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 139. CANADA SOFTGEL CAPSULES MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 140. CANADA SOFTGEL CAPSULES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. CANADA SOFTGEL CAPSULES MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 142. CANADA SOFTGEL CAPSULES MARKET SIZE, BY NATURE OF RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 143. CANADA SOFTGEL CAPSULES MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
TABLE 144. CANADA SOFTGEL CAPSULES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 145. CANADA SOFTGEL CAPSULES MARKET SIZE, BY POLYDOSE, 2018-2030 (USD MILLION)
TABLE 146. CANADA SOFTGEL CAPSULES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 147. CANADA SOFTGEL CAPSULES MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 148. CANADA SOFTGEL CAPSULES MARKET SIZE, BY MARINE-ORIGIN, 2018-2030 (USD MILLION)
TABLE 149. CANADA SOFTGEL CAPSULES MARKET SIZE, BY END INDUSTRY, 2018-2030 (USD MILLION)
TABLE 150. CANADA SOFTGEL CAPSULES MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, 2018-2030 (USD MILLION)
TABLE 151. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 153. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY NON-GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 154. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY PULLULAN, 2018-2030 (USD MILLION)
TABLE 155. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 157. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY VITAMINS AND MINERALS, 2018-2030 (USD MILLION)
TABLE 158. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY OMEGA-3, 2018-2030 (USD MILLION)
TABLE 159. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 160. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 161. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 163. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY NATURE OF RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 164. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
TABLE 165. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 166. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY POLYDOSE, 2018-2030 (USD MILLION)
TABLE 167. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 168. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 169. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY MARINE-ORIGIN, 2018-2030 (USD MILLION)
TABLE 170. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY END INDUSTRY, 2018-2030 (USD MILLION)
TABLE 171. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY NON-GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY PULLULAN, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY VITAMINS AND MINERALS, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY OMEGA-3, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY NATURE OF RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY POLYDOSE, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY MARINE-ORIGIN, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY END INDUSTRY, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY NON-GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY PULLULAN, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY VITAMINS AND MINERALS, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY OMEGA-3, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY NATURE OF RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY POLYDOSE, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY MARINE-ORIGIN, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY END INDUSTRY, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY NON-GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY PULLULAN, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 222. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY VITAMINS AND MINERALS, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY OMEGA-3, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY NATURE OF RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY POLYDOSE, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY MARINE-ORIGIN, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY END INDUSTRY, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, 2018-2030 (USD MILLION)
TABLE 237. CHINA SOFTGEL CAPSULES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. CHINA SOFTGEL CAPSULES MARKET SIZE, BY GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 239. CHINA SOFTGEL CAPSULES MARKET SIZE, BY NON-GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 240. CHINA SOFTGEL CAPSULES MARKET SIZE, BY PULLULAN, 2018-2030 (USD MILLION)
TABLE 241. CHINA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. CHINA SOFTGEL CAPSULES MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 243. CHINA SOFTGEL CAPSULES MARKET SIZE, BY VITAMINS AND MINERALS, 2018-2030 (USD MILLION)
TABLE 244. CHINA SOFTGEL CAPSULES MARKET SIZE, BY OMEGA-3, 2018-2030 (USD MILLION)
TABLE 245. CHINA SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 246. CHINA SOFTGEL CAPSULES MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 247. CHINA SOFTGEL CAPSULES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 248. CHINA SOFTGEL CAPSULES MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 249. CHINA SOFTGEL CAPSULES MARKET SIZE, BY NATURE OF RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 250. CHINA SOFTGEL CAPSULES MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
TABLE 251. CHINA SOFTGEL CAPSULES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 252. CHINA SOFTGEL CAPSULES MARKET SIZE, BY POLYDOSE, 2018-2030 (USD MILLION)
TABLE 253. CHINA SOFTGEL CAPSULES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 254. CHINA SOFTGEL CAPSULES MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 255. CHINA SOFTGEL CAPSULES MARKET SIZE, BY MARINE-ORIGIN, 2018-2030 (USD MILLION)
TABLE 256. CHINA SOFTGEL CAPSULES MARKET SIZE, BY END INDUSTRY, 2018-2030 (USD MILLION)
TABLE 257. CHINA SOFTGEL CAPSULES MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, 2018-2030 (USD MILLION)
TABLE 258. INDIA SOFTGEL CAPSULES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. INDIA SOFTGEL CAPSULES MARKET SIZE, BY GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 260. INDIA SOFTGEL CAPSULES MARKET SIZE, BY NON-GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 261. INDIA SOFTGEL CAPSULES MARKET SIZE, BY PULLULAN, 2018-2030 (USD MILLION)
TABLE 262. INDIA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. INDIA SOFTGEL CAPSULES MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 264. INDIA SOFTGEL CAPSULES MARKET SIZE, BY VITAMINS AND MINERALS, 2018-2030 (USD MILLION)
TABLE 265. INDIA SOFTGEL CAPSULES MARKET SIZE, BY OMEGA-3, 2018-2030 (USD MILLION)
TABLE 266. INDIA SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 267. INDIA SOFTGEL CAPSULES MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 268. INDIA SOFTGEL CAPSULES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 269. INDIA SOFTGEL CAPSULES MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 270. INDIA SOFTGEL CAPSULES MARKET SIZE, BY NATURE OF RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 271. INDIA SOFTGEL CAPSULES MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
TABLE 272. INDIA SOFTGEL CAPSULES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 273. INDIA SOFTGEL CAPSULES MARKET SIZE, BY POLYDOSE, 2018-2030 (USD MILLION)
TABLE 274. INDIA SOFTGEL CAPSULES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 275. INDIA SOFTGEL CAPSULES MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 276. INDIA SOFTGEL CAPSULES MARKET SIZE, BY MARINE-ORIGIN, 2018-2030 (USD MILLION)
TABLE 277. INDIA SOFTGEL CAPSULES MARKET SIZE, BY END INDUSTRY, 2018-2030 (USD MILLION)
TABLE 278. INDIA SOFTGEL CAPSULES MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY NON-GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY PULLULAN, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY VITAMINS AND MINERALS, 2018-2030 (USD MILLION)
TABLE 286. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY OMEGA-3, 2018-2030 (USD MILLION)
TABLE 287. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 288. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 289. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 290. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 291. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY NATURE OF RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 292. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
TABLE 293. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 294. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY POLYDOSE, 2018-2030 (USD MILLION)
TABLE 295. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 296. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 297. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY MARINE-ORIGIN, 2018-2030 (USD MILLION)
TABLE 298. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY END INDUSTRY, 2018-2030 (USD MILLION)
TABLE 299. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, 2018-2030 (USD MILLION)
TABLE 300. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 301. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 302. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY NON-GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 303. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY PULLULAN, 2018-2030 (USD MILLION)
TABLE 304. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 306. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY VITAMINS AND MINERALS, 2018-2030 (USD MILLION)
TABLE 307. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY OMEGA-3, 2018-2030 (USD MILLION)
TABLE 308. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 309. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 310. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 311. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 312. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY NATURE OF RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 313. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
TABLE 314. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 315. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY POLYDOSE, 2018-2030 (USD MILLION)
TABLE 316. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 317. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 318. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY MARINE-ORIGIN, 2018-2030 (USD MILLION)
TABLE 319. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY END INDUSTRY, 2018-2030 (USD MILLION)
TABLE 320. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, 2018-2030 (USD MILLION)
TABLE 321. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 322. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 323. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY NON-GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 324. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY PULLULAN, 2018-2030 (USD MILLION)
TABLE 325. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 326. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 327. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY VITAMINS AND MINERALS, 2018-2030 (USD MILLION)
TABLE 328. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY OMEGA-3, 2018-2030 (USD MILLION)
TABLE 329. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 330. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 331. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 332. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 333. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY NATURE OF RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 334. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
TABLE 335. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 336. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY POLYDOSE, 2018-2030 (USD MILLION)
TABLE 337. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY NATURAL, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY MARINE-ORIGIN, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY END INDUSTRY, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY FOOD AND BEVERAGE INDUSTRY, 2018-2030 (USD MILLION)
TABLE 342. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 343. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 344. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY NON-GELATIN CAPSULES, 2018-2030 (USD MILLION)
TABLE 345. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY PULLULAN, 2018-2030 (USD MILLION)
TABLE 346. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 347. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY NUTRACEUTICAL, 2018-2030 (USD MILLION)
TABLE 348. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY VITAMINS AND MINERALS, 2018-2030 (USD MILLION)
TABLE 349. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY OMEGA-3, 2018-2030 (USD MILLION)
TABLE 350. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 351. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 352. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 353. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 354. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY NATURE OF RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 355. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY ANIMAL-BASED, 2018-2030 (USD MILLION)
TABLE 356. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 357. PHILIP

Companies Mentioned

  • Aenova Group GmbH
  • Amway Corporation
  • BASF SE
  • Captek Softgel International Inc
  • Catalent, Inc.
  • Curtis Health Caps
  • Delpharm
  • Elnova Pharma
  • Fortunelabs
  • Fuji Capsules Co Ltd.
  • Hunan Kang Pharmaceutical Limited
  • InovoBiologic Inc.
  • International Flavors & Fragrances Inc.
  • Marksans Pharma Limited
  • Natural Factors
  • Nature's Bounty Co.
  • Qualicaps Co., Ltd.
  • Rocket Science Supplements Ltd.
  • Roquette Frères
  • SaintyCo
  • Sirio Pharma Co., Ltd. by Pfizer Inc.
  • Soft Gel Technologies, Inc.
  • Softigel by Procaps Group
  • Strides Pharma Science Limited
  • Thermo Fisher Scientific, Inc.
  • Trigen Laboratories Inc.
  • United Laboratories
  • Weihai Baihe Biology Technological Co Ltd.
  • Yuwang Group

Methodology

Loading
LOADING...